Venous disease and lymphedema treatment took a step forward with Koya Medical’s $30M financing. The 2020 Rosenman Innovator will continue […]
Koya Medical Raises $30M

Venous disease and lymphedema treatment took a step forward with Koya Medical’s $30M financing. The 2020 Rosenman Innovator will continue […]
Neurovalens, a 2022 Rosenman Innovator, received FDA 510(k) clearance for their non-invasive device to treat chronic insomnia with electrical pulses. […]
The specialty care platform built for the tens of millions of women living with hormonal and gynecologic conditions, Allara Health, […]
Midi Health, a 2022 ADAPT finalist, is on a mission to revolutionize midlife care for women, and they’ve just hit […]
Targeted drug delivery technology takes a step forward with Suono Bio’s exclusive patent option agreement for the first-in-kind “RoboCap” electromechanical […]
With little change in the tampon design for nearly a century, an innovative new design may soon hit the shelves. […]
Suono Bio’s ultrasound-mediated drug delivery platform shows promising outcomes in its first-in-human study, demonstrating encouraging results. This is the first […]
Visana Health, a 2021 UCSF Rosenman ADAPT Awardee, secured $10.1 million in seed funding. The funding will allow Visana to […]
Enspectra Health, a 2018 Rosenman Innovator and 2022 UCSF Rosenman RISE company pioneering the virtual biopsy, was awarded a $2M […]
Candesant Biomedical has secured a $35M Series B following FDA clearance for their pioneering anti-sweat patch. This financial boost led […]